© 1999 by Oxford University Press
Journal of the National Cancer Institute, Vol. 91, No. 9, 779-786,
May 5, 1999
© 1999 Oxford University Press
REPORTS |
Cancer, Heart Disease, and Diabetes in Workers Exposed to 2,3,7,8-Tetrachlorodibenzo-p-dioxin
Affiliation of authors: National Institute for Occupational Safety and Health, Cincinnati, OH.
Correspondence to: Kyle Steenland, Ph.D., International Agency for Research on Cancer, 150 Cours Albert Thomas, 69372 Lyon, France (e-mail: steenland{at}iarc.fr).
BACKGROUND: In 1997, the International Agency for Research on Cancer classified 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) as a group 1 human carcinogen, based largely on four highly exposed industrial cohorts that showed an excess of all cancers combined. In this study, we extended the follow-up period for the largest of these cohorts by 6 years and developed a job-exposure matrix. METHODS: We did cohort mortality analyses involving 5132 chemical workers at 12 U.S. plants by use of life table techniques (U.S. population referent) and Cox regression (internal referent). We conducted exposure-response analyses for 69% of the cohort with adequate work history data and adequate plant data on TCDD contamination. All P values are two-sided. RESULTS: The standardized mortality ratio (SMR) for all cancers combined was 1.13 (95% confidence interval = 1.02-1.25). We found statistically significant positive linear trends in SMRs with increasing exposure for all cancers combined and for lung cancer. The SMR for all cancers combined for the highest exposure group was 1.60 (95% confidence interval = 1.15-1.82). SMRs for heart disease showed a weak increasing trend with higher exposure (P = .14). Diabetes (any mention on the death certificate) showed a negative exposure-response trend. Internal analyses with Cox regression found statistically significant trends for cancer (15-year lag time) and heart disease (no lag). CONCLUSIONS: Our analyses suggest that high TCDD exposure results in an excess of all cancers combined, without any marked specificity. However, excess cancer was limited to the highest exposed workers, with exposures that were likely to have been 100-1000 times higher than those experienced by the general population and similar to the TCDD levels used in animal studies.
This article has been cited by other articles:
![]() |
D. Consonni, A. C. Pesatori, C. Zocchetti, R. Sindaco, L. C. D'Oro, M. Rubagotti, and P. A. Bertazzi Mortality in a Population Exposed to Dioxin after the Seveso, Italy, Accident in 1976: 25 Years of Follow-Up Am. J. Epidemiol., April 1, 2008; 167(7): 847 - 858. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yoshizawa, A. Heatherly, D. E. Malarkey, N. J. Walker, and A. Nyska A Critical Comparison of Murine Pathology and Epidemiological Data of TCDD, PCB126, and PeCDF Toxicol Pathol, December 1, 2007; 35(7): 865 - 879. [Abstract] [PDF] |
||||
![]() |
D.-H. Lee, I.-K. Lee, K. Song, M. Steffes, W. Toscano, B. A. Baker, and D. R. Jacobs Jr A Strong Dose-Response Relation Between Serum Concentrations of Persistent Organic Pollutants and Diabetes: Results from the National Health and Examination Survey 1999-2002 Diabetes Care, July 1, 2006; 29(7): 1638 - 1644. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-H. Ueng, C.-C. Hung, M.-L. Kuo, P.-K. Chan, S.-H. Hu, P.-C. Yang, and L. W. Chang Induction of Fibroblast Growth Factor-9 and Interleukin-1{alpha} Gene Expression by Motorcycle Exhaust Particulate Extracts and Benzo(a)pyrene in Human Lung Adenocarcinoma Cells Toxicol. Sci., October 1, 2005; 87(2): 483 - 496. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-A. Li and P.-W. Wang PCB126 Induces Differential Changes in Androgen, Cortisol, and Aldosterone Biosynthesis in Human Adrenocortical H295R Cells Toxicol. Sci., May 1, 2005; 85(1): 530 - 540. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yoshizawa, T. Marsh, J. F. Foley, B. Cai, S. Peddada, N. J. Walker, and A. Nyska Mechanisms of Exocrine Pancreatic Toxicity Induced by Oral Treatment with 2,3,7,8-Tetrachlorodibenzo-p-Dioxin in Female Harlan Sprague-Dawley Rats Toxicol. Sci., May 1, 2005; 85(1): 594 - 606. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Martinez, S. J. Baek, D. M. Mays, P. K. Tithof, T. E. Eling, and N. J. Walker EGR1 Is a Novel Target for AhR Agonists in Human Lung Epithelial Cells Toxicol. Sci., December 1, 2004; 82(2): 429 - 435. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Marlowe, E. S. Knudsen, S. Schwemberger, and A. Puga The Aryl Hydrocarbon Receptor Displaces p300 from E2F-dependent Promoters and Represses S Phase-specific Gene Expression J. Biol. Chem., July 9, 2004; 279(28): 29013 - 29022. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Marchand, R. Barouki, and M. Garlatti Regulation of NAD(P)H:Quinone Oxidoreductase 1 Gene Expression by CYP1A1 Activity Mol. Pharmacol., April 1, 2004; 65(4): 1029 - 1037. [Abstract] [Full Text] |
||||
![]() |
K M Bodner, J J Collins, L J Bloemen, and M L Carson Cancer risk for chemical workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin Occup. Environ. Med., September 1, 2003; 60(9): 672 - 675. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Frumkin Agent Orange and Cancer: An Overview for Clinicians CA Cancer J Clin, July 1, 2003; 53(4): 245 - 255. [Abstract] [Full Text] [PDF] |
||||
![]() |
A 't Mannetje, K Steenland, M Attfield, P Boffetta, H Checkoway, N DeKlerk, and R-S Koskela Exposure-response analysis and risk assessment for silica and silicosis mortality in a pooled analysis of six cohorts Occup. Environ. Med., November 1, 2002; 59(11): 723 - 728. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Martinez, C. A. Afshari, P. R. Bushel, A. Masuda, T. Takahashi, and N. J. Walker Differential Toxicogenomic Responses to 2,3,7,8-Tetrachlorodibenzo-p-dioxin in Malignant and Nonmalignant Human Airway Epithelial Cells Toxicol. Sci., October 1, 2002; 69(2): 409 - 423. [Abstract] [Full Text] [PDF] |
||||
![]() |
K Steenland, G Calvert, N Ketchum, and J Michalek Dioxin and diabetes mellitus: an analysis of the combined NIOSH and Ranch Hand data Occup. Environ. Med., October 1, 2001; 58(10): 641 - 648. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Steenland, J. Deddens, and L. Piacitelli Risk Assessment for 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD) based on an Epidemiologic Study Am. J. Epidemiol., September 1, 2001; 154(5): 451 - 458. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Bertazzi, D. Consonni, S. Bachetti, M. Rubagotti, A. Baccarelli, C. Zocchetti, and A. C. Pesatori Health Effects of Dioxin Exposure: A 20-Year Mortality Study Am. J. Epidemiol., June 1, 2001; 153(11): 1031 - 1044. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Bertazzi, D. Consonni, S. Bachetti, M. Rubagotti, A. Baccarelli, C. Zocchetti, and A. C. Pesatori Bertazzi et al. Respond to Smith and Lopipero Am. J. Epidemiol., June 1, 2001; 153(11): 1048 - 1049. [Full Text] [PDF] |
||||
![]() |
X. Coumoul, M. Diry, C. Robillot, and R. Barouki Differential Regulation of Cytochrome P450 1A1 and 1B1 by a Combination of Dioxin and Pesticides in the Breast Tumor Cell Line MCF-7 Cancer Res., May 1, 2001; 61(10): 3942 - 3948. [Abstract] [Full Text] |
||||
![]() |
A. M. Tritscher, J. Mahler, C. J. Portier, G. W. Lucier, and N. J. Walker Induction of Lung Lesions in Female Rats Following Chronic Exposure to 2,3,7,8-Tetrachlorodibenzo-p-dioxin Toxicol Pathol, November 1, 2000; 28(6): 761 - 769. [Abstract] [PDF] |
||||
![]() |
G. M. Solomon and T. Schettler Environment and health: 6. Endocrine disruption and potential human health implications Can. Med. Assoc. J., November 1, 2000; 163(11): 1471 - 1476. [Full Text] [PDF] |
||||
![]() |
A. M. Ekstrom, M. Eriksson, L.-E. Hansson, A. Lindgren, L. B. Signorello, O. Nyren, and L. Hardell Occupational Exposures and Risk of Gastric Cancer in a Population-basedCase-Control Study Cancer Res., December 1, 1999; 59(23): 5932 - 5937. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. N. Hoover Dioxin Dilemmas J Natl Cancer Inst, May 5, 1999; 91(9): 745 - 746. [Full Text] [PDF] |
||||










